142 related articles for article (PubMed ID: 30389815)
1. An International Survey on Clinical Reporting of PET/CT Examinations: A Starting Point for Cross-Specialty Engagement.
Freudenberg LS; Hicks RJ; Beyer T
J Nucl Med; 2019 Apr; 60(4):480-485. PubMed ID: 30389815
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. SNMMI Procedure Standard/EANM Practice Guideline on Pediatric
Vali R; Alessio A; Balza R; Borgwardt L; Bar-Sever Z; Czachowski M; Jehanno N; Kurch L; Pandit-Taskar N; Parisi M; Piccardo A; Seghers V; Shulkin BL; Zucchetta P; Lim R
J Nucl Med; 2021 Jan; 62(1):99-110. PubMed ID: 33334912
[TBL] [Abstract][Full Text] [Related]
4. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
Høilund-Carlsen PF
Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
[TBL] [Abstract][Full Text] [Related]
5. Variation of system performance, quality control standards and adherence to international FDG-PET/CT imaging guidelines. A national survey of PET/CT operations in Austria.
Rausch I; Bergmann H; Geist B; Schaffarich M; Hirtl A; Hacker M; Beyer T
Nuklearmedizin; 2014; 53(6):242-8. PubMed ID: 25131649
[TBL] [Abstract][Full Text] [Related]
6. Oncologic PET/CT interpretation and reporting approaches. Survey in clinical practice.
Karantanis D; Kalkanis D; Allen-Auerbach MS; Herrmann K; Pomykala KL; Bogsrud TV; Lowe VJ; Czernin J
Nuklearmedizin; 2014; 53(2):19-25. PubMed ID: 24473996
[TBL] [Abstract][Full Text] [Related]
7. Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.
Grammaticos P; Zerva C; Asteriadis I; Trontzos C; Hatziioannou K
Hell J Nucl Med; 2007; 10(2):74-6. PubMed ID: 17684579
[TBL] [Abstract][Full Text] [Related]
8. Variations in PET/MRI Operations: Results from an International Survey Among 39 Active Sites.
Fendler WP; Czernin J; Herrmann K; Beyer T
J Nucl Med; 2016 Dec; 57(12):2016-2021. PubMed ID: 27516448
[TBL] [Abstract][Full Text] [Related]
9. An international survey on hybrid imaging: do technology advances preempt our training and education efforts?
Beyer T; Hicks R; Brun C; Antoch G; Freudenberg LS
Cancer Imaging; 2018 Apr; 18(1):15. PubMed ID: 29695290
[TBL] [Abstract][Full Text] [Related]
10. Oncologic 18F-FDG PET/CT: referring physicians' point of view.
Karantanis D; Kalkanis D; Allen-Auerbach M; Bogsrud TV; Subramaniam RM; Danielson A; Lowe VJ; Czernin J
J Nucl Med; 2012 Oct; 53(10):1499-505. PubMed ID: 22917886
[TBL] [Abstract][Full Text] [Related]
11. Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).
Nanni C; Versari A; Chauvie S; Bertone E; Bianchi A; Rensi M; Bellò M; Gallamini A; Patriarca F; Gay F; Gamberi B; Ghedini P; Cavo M; Fanti S; Zamagni E
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):712-719. PubMed ID: 29270787
[TBL] [Abstract][Full Text] [Related]
12. Actionable reporting versus unwanted advice in PET-CT reports.
Pencharz D; Wagner T
Clin Radiol; 2023 Sep; 78(9):666-670. PubMed ID: 37349201
[TBL] [Abstract][Full Text] [Related]
13. Current trends in pediatric nuclear medicine: a Society for Pediatric Radiology membership survey.
Sammer MBK; Sher AC; States LJ; Trout AT; Seghers VJ
Pediatr Radiol; 2020 Jul; 50(8):1139-1147. PubMed ID: 32399687
[TBL] [Abstract][Full Text] [Related]
14.
Dercle L; Seban RD; Lazarovici J; Schwartz LH; Houot R; Ammari S; Danu A; Edeline V; Marabelle A; Ribrag V; Michot JM
J Nucl Med; 2018 Jan; 59(1):15-24. PubMed ID: 28596157
[TBL] [Abstract][Full Text] [Related]
15. Imaging modalities for the staging of patients with colorectal cancer.
Bipat S; Niekel MC; Comans EF; Nio CY; Bemelman WA; Verhoef C; Stoker J
Neth J Med; 2012 Jan; 70(1):26-34. PubMed ID: 22271811
[TBL] [Abstract][Full Text] [Related]
16. Standardization of [F-18]FDG PET/CT for response evaluation by the Radiologic Society of North America-Quantitative Imaging Biomarker Alliance (RSNA-QIBA) profile: preliminary results from the Japan-QIBA (J-QIBA) activities for Asian international multicenter phase II trial.
Bae H; Tsuchiya J; Okamoto T; Ito I; Sonehara Y; Nagahama F; Kubota K; Tateishi U
Jpn J Radiol; 2018 Nov; 36(11):686-690. PubMed ID: 30251115
[TBL] [Abstract][Full Text] [Related]
17. Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of
Isik EG; Kuyumcu S; Kebudi R; Sanli Y; Karakas Z; Cakir FB; Unal SN
Ann Nucl Med; 2017 Nov; 31(9):660-668. PubMed ID: 28741053
[TBL] [Abstract][Full Text] [Related]
18. Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring.
Minamimoto R; Fayad L; Advani R; Vose J; Macapinlac H; Meza J; Hankins J; Mottaghy F; Juweid M; Quon A
Radiology; 2016 Jul; 280(1):220-9. PubMed ID: 26854705
[TBL] [Abstract][Full Text] [Related]
19. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
[TBL] [Abstract][Full Text] [Related]
20. International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers.
Biggi A; Gallamini A; Chauvie S; Hutchings M; Kostakoglu L; Gregianin M; Meignan M; Malkowski B; Hofman MS; Barrington SF
J Nucl Med; 2013 May; 54(5):683-90. PubMed ID: 23516309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
